Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ 07852, NDC 71384-340-08
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #: 23JUN031; Exp. 07/03/2024
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Imprimis NJOF, LLC
- Reason for Recall:
- Subpotent Drug
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- ongoing
Product Information
Full Description:
Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ 07852, NDC 71384-340-08
Product Codes/Lot Numbers:
Lot #: 23JUN031; Exp. 07/03/2024
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0476-2024
Related Recalls
Class I - Dangerous
Subpotent Drug
Class I - Dangerous
Sub-Potent Drug: Subpotent assay results during stability testing.
Class I - Dangerous
Sub-Potent Drug: Subpotent assay results during stability testing.